HR Execs on the Move

Boston Health Care for the Homeless Program

www.bhchp.org

 
Since its founding in 1985, Boston Health Care for the Homeless Program has been guided by a simple mission - to provide and assure access to the highest quality health care for Bostons homeless men, women and children. http://www.bhchp.org
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.bhchp.org
  • 780, Albany Street
    Boston, MA USA 02118
  • Phone: 857.654.1000

Executives

Name Title Contact Details

Similar Companies

Prilenia

We are a clinical stage biotech startup, led by Michael Hayden, MD, PhD., together with a highly experienced team with a track record of success. Michael is the founder of five biotech companies and was previously President of Global R&D and Chief Scientific Officer at Teva. He has directed the development of multiple innovative drug products leading to 35 approvals between 2012-2018.

HealthWarehouse.com

HealthWarehouse.com is a trusted VIPPS accredited online pharmacy based in Florence, Kentucky. The Company is focused on the growing out of pocket prescription market, which is expected to grow to $80 billion in 2015. With a mission to provide affordable healthcare to every American by focusing on technology that is revolutionizing prescription delivery, HealthWarehouse.com has become the largest VIPPS accredited online pharmacy in the United States. HealthWarehouse.com is licensed in all 50 states and only sells drugs that are FDA-approved and legal for sale in the United States.

Western Wisconsin Health

Western Wisconsin Health is a health clinic offering a range of traditional and natural health services. Learn more about our Roberts and Baldwin health centers today.

GMP Contractors

GMP Contractors is a Bear, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aclaris Therapeutics

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.